Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biomed Pharmacother ; 163: 114710, 2023 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-37141737

RESUMO

α-Mangostin (α-MG) is a natural xanthone obtained from the pericarps of mangosteen. It exhibits excellent potential, including anti-cancer, neuroprotective, antimicrobial, antioxidant, and anti-inflammatory properties, and induces apoptosis. α-MG controls cell proliferation by modulating signaling molecules, thus implicated in cancer therapy. It possesses incredible pharmacological features and modulates crucial cellular and molecular factors. Due to its lesser water solubility and pitiable target selectivity, α-MG has limited clinical application. As a known antioxidant, α-MG has gained significant attention from the scientific community, increasing interest in extensive technical and biomedical applications. Nanoparticle-based drug delivery systems were designed to improve the pharmacological features and efficiency of α-MG. This review is focused on recent developments on the therapeutic potential of α-MG in managing cancer and neurological diseases, with a special focus on its mechanism of action. In addition, we highlighted biochemical and pharmacological features, metabolism, functions, anti-inflammatory, antioxidant effects and pre-clinical applications of α-MG.


Assuntos
Neoplasias , Xantonas , Humanos , Antioxidantes/farmacologia , Antioxidantes/uso terapêutico , Apoptose , Xantonas/farmacologia , Xantonas/uso terapêutico , Xantonas/química , Solubilidade , Neoplasias/tratamento farmacológico
2.
Polymers (Basel) ; 15(3)2023 Jan 24.
Artigo em Inglês | MEDLINE | ID: mdl-36771900

RESUMO

Global climate change is already affecting the environment, as glaciers are receding, ice on rivers and lakes is melting, plant and animal range`s have altering, and trees are blooming early. Therefore, focus has shifted towards sustainable materials. There is a growing desire for materials that have a unique combination of qualities that metals, polymers, and other materials cannot provide, therefore scientists are turning their focus to green composites. Green composites offer a wide range of uses in automotive, aerospace, and marine applications. Composites are multiphase resources with separate interfaces that contain chemically different materials. Composites are made up of a variety of materials that are distinct in nature, and they give a set of desirable features that are superior to those of their predecessors or parents. Natural fibers are less expensive, more readily available, rust-resistant, plentiful, nontoxic, and safe for human skin, eyes, and respiratory systems. Green composites are created by combining renewable fibers with polymers (matrix) to create a new class of composites known as "green composites." This review includes studies on various animal-based fibers and their applications. In this article, recent advancements in the field of these fibers and their composites of fibers are also discussed. The physical, chemical, and mechanical properties are also discussed in this paper. Moreover, the benefits and drawbacks of using these fibers are also discussed in detail. Finally, the paper gives an outline of the topic. The results from composites constructed from each fiber are provided, along with appropriate references for more in-depth analysis studies. This review is specially performed to strengthen the knowledge bank of the young researchers working in the field of natural composites.

3.
Biochim Biophys Acta Mol Basis Dis ; 1866(10): 165878, 2020 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-32544429

RESUMO

The sudden emergence of severe respiratory disease, caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently become a public health emergency. Genome sequence analysis of SARS-CoV-2 revealed its close resemblance to the earlier reported SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV). However, initial testing of the drugs used against SARS-CoV and MERS-CoV has been ineffective in controlling SARS-CoV-2. The present study highlights the genomic, proteomic, pathogenesis, and therapeutic strategies in SARS-CoV-2 infection. We have carried out sequence analysis of potential drug target proteins in SARS-CoV-2 and, compared them with SARS-CoV and MERS viruses. Analysis of mutations in the coding and non-coding regions, genetic diversity, and pathogenicity of SARS-CoV-2 has also been done. A detailed structural analysis of drug target proteins has been performed to gain insights into the mechanism of pathogenesis, structure-function relationships, and the development of structure-guided therapeutic approaches. The cytokine profiling and inflammatory signalling are different in the case of SARS-CoV-2 infection. We also highlighted possible therapies and their mechanism of action followed by clinical manifestation. Our analysis suggests a minimal variation in the genome sequence of SARS-CoV-2, may be responsible for a drastic change in the structures of target proteins, which makes available drugs ineffective.


Assuntos
Betacoronavirus/genética , Genoma Viral , Betacoronavirus/isolamento & purificação , Betacoronavirus/patogenicidade , COVID-19 , Infecções por Coronavirus/tratamento farmacológico , Infecções por Coronavirus/patologia , Infecções por Coronavirus/virologia , Citocinas/metabolismo , Variação Genética , Humanos , Coronavírus da Síndrome Respiratória do Oriente Médio/genética , Coronavírus da Síndrome Respiratória do Oriente Médio/isolamento & purificação , Coronavírus da Síndrome Respiratória do Oriente Médio/patogenicidade , Pandemias , Pneumonia Viral/tratamento farmacológico , Pneumonia Viral/patologia , Pneumonia Viral/virologia , RNA Polimerase Dependente de RNA/genética , SARS-CoV-2 , Glicoproteína da Espícula de Coronavírus/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...